Physician profile
Alan C Schlaerth
NPI 1043239049
$25,914.22
in general payments reported to CMS, 2019-2025
15 companies · $8,374 in 2025
The $8,374 reported for 2025 was more than what 90% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,899 · 2020: $506 · 2021: $5,471 · 2022: $344 · 2023: $499 · 2024: $6,821 · 2025: $8,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $1,960 · Travel and Lodging: $1,885 · Education: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,349.28 |
| Food and Beverage | $1,960.46 |
| Travel and Lodging | $1,884.93 |
| Education | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,422.79 | 2019-2025 | |
| Medical Device Business Services, INC. | $6,635.16 | 2021-2024 | Harmonic, Enseal X1 |
| Ethicon US, LLC | $5,881.18 | 2019-2025 | Enseal X1, Enseal, Endopath Xcel |
| Abbvie INC. | $655.00 | 2019-2021 | |
| Medtronic, INC. | $406.90 | 2023 | Ligasure, Signia |
| Apyx Medical Corporation | $332.90 | 2019-2020 | |
| Covidien LP | $141.91 | 2019 | |
| Acacia Pharma INC | $126.53 | 2021 | |
| Mimedx Group, INC. | $123.05 | 2025 | |
| Baxter Healthcare | $50.31 | 2025 | Floseal |
| Merck Sharp & Dohme LLC | $33.25 | 2023 | Keytruda |
| Biom'Up France Sas | $32.65 | 2021 | |
| Davol INC. | $29.67 | 2019 | |
| Boston Scientific Corporation | $27.77 | 2025 | General - Pain Management |
| Coloplast Corp | $15.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Schlaerth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.